Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Regulatory Peptides|February 1, 2005
Basal adrenocorticotropin (ACTH) secretion is negatively modulated by protein phosphatase 5 in mouse pituitary corticotropin AtT20 cellsFeng Liu, Xavier Khawaja
Journal of Molecular Neuroscience : MN|May 7, 2009
The role of melanin-concentrating hormone in energy homeostasis and mood disordersIldiko Antal-Zimanyi, Xavier Khawaja
Expert Opinion on Drug Discovery|March 19, 2013
Scintillation proximity assay in lead discoveryXavier Khawaja, John Dunlop, Dianne Kowal
Journal of Pharmacological and Toxicological Methods|December 26, 2006
Stable expression of adenylyl cyclase 2 leads to the functional rescue of human 5-HT6 receptor in a CHODUKX cell lineStanley P Nawoschik, Michael Olsen, Deborah L Smith, et al.
Journal of Neuroscience Research|January 27, 2004
Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapiesXavier Khawaja, Jun Xu, Jin-Jun Liang, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Innovative approaches for the development of antidepressant drugs: current and future strategiesLee E Schechter, Robert H Ring, Chad E Beyer, et al.
European Journal of Pharmacology|August 5, 2008
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmissionBrian A Hoshaw, Tiffany I Hill, James J Crowley, et al.
Pharmacology & Therapeutics|October 3, 2006
Differentiating antidepressants of the future: efficacy and safetySharon Rosenzweig-Lipson, Chad E Beyer, Zoë A Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2010
3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studiesAdam M Gilbert, Matthew G Bursavich, Sabrina Lombardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2008
ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activitiesFeng Liu, Steve Grauer, Cody Kelley, et al.
Pageof 1